Redirection of CMV-specific CTL towards B-CLL via CD20-targeted HLA/CMV complexes
Open Access
- 23 March 2006
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 20 (6) , 1096-1102
Abstract
B-cell chronic lymphocytic leukaemia (B-CLL) is a slowly progressing malignancy of CD5+ B cells, for which at present no curative treatment is available. In our current study, we apply a novel bridging reagent to redirect cytomegalovirus (CMV)-specific cytotoxic T lymphocytes (CTL) to target B-CLL. A streptavidin-fused anti-CD20 single-chain variable fragment (scFv) is used in combination with biotinylated MHC class I molecules containing CMV pp65 peptide (HLA/CMV). We demonstrate that B-CLL cells coated with this CD20-HLA/CMV complex can be lysed by autologous CMV-specific CTL with similar efficiency as B-CLL cells directly loaded with CMV peptide. Killing is HLA restricted and occurs at scFv CD20 concentrations of ⩾ 100 ng ml−1 and HLA/CMV concentrations of ⩾ 20 ng ml−1. Furthermore, complex-coated B-CLL cells induce both proliferation and cytokine production (interferon γ, tumour necrosis factor α and macrophage inflammatory protein−1 β) in CMV-specific CD8+ T cells. Hereby, a necessary step towards possible application of CD20-HLA/CMV complexes for immunotherapy of B-cell malignancies is constituted.Keywords
This publication has 29 references indexed in Scilit:
- Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLLLeukemia, 2004
- Autologous cytomegalovirus-specific T cells as effector cells in immunotherapy of B cell chronic lymphocytic leukaemiaBritish Journal of Haematology, 2004
- Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphomaBlood, 2004
- Guidelines on the diagnosis and management of chronic lymphocytic leukaemiaBritish Journal of Haematology, 2004
- Antibody-targeted MHC complex–directed expansion of HIV-1– and KSHV-specific CD8+ lymphocytes: a new approach to therapeutic vaccinationBlood, 2004
- Interferon-γ: an overview of signals, mechanisms and functionsJournal of Leukocyte Biology, 2003
- Differentiation of cytomegalovirus-specific CD8+ T cells in healthy and immunosuppressed virus carriersBlood, 2001
- Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodiesThe Hematology Journal, 2001
- Aberrant expression and reverse signalling of CD70 on malignant B cellsBritish Journal of Haematology, 1999
- Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)Nature, 1995